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Summary
Mutations in the connexin 26 (Cx26) gene (GJB2) are
associated with the type of autosomal recessive nonsyn-
dromic neurosensory deafness known as “DFNB1.”
Studies indicate that DFNB1 (13q11-12) causes 20% of
all childhood deafness and may have a carrier rate as
high as 2.8%. This study describes the analysis of 58
multiplex families each having at least two affected chil-
dren diagnosed with autosomal recessive nonsyndromic
deafness. Twenty of the 58 families were observed to
have mutations in both alleles of Cx26. Thirty-three of
116 chromosomes contained a 30delG allele, for a fre-
quency of .284. This mutation was observed in 2 of 192
control chromosomes, for an estimated gene frequency
of . The homozygous frequency of the.01 .007
30delG allele is then estimated at .0001, or 1/10,000.
Given that the frequency of all childhood hearing im-
pairment is 1/1,000 and that half of that is genetic, the
specific mutation 30delG is responsible for 10% of all
childhood hearing loss and for 20% of all childhood
hereditary hearing loss. Six novel mutations were also
observed in the affected population. The deletions de-
tected cause frameshifts that would severely disrupt the
protein structure. Three novel missense mutations,
Val84Met, Val95Met, and Ser113Pro, were observed.
The missense mutation 101TrC has been reported to
be a dominant allele of DFNA3, a dominant nonsyn-
dromic hearing loss. Data further supporting the finding
that this mutation does not cause dominant hearing loss
are presented. This allele was found in a recessive family
segregating independently from the hearing-loss phe-
notype and in 3 of 192 control chromosomes. These
results indicate that 101TrC is not sufficient to cause
hearing loss.
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Introduction
Mutations in the connexin 26 (Cx26) gene (GJB2),
which is located on chromosome 13q11-12, are asso-
ciated with the autosomal recessive nonsyndromic neu-
rosensory deafness known as “DFNB1” (MIM 220290)
(Chaib et al. 1994; Carrasquillo et al. 1997; Denoyelle
et al. 1997; Kelsell et al. 1997; Van Camp et al. 1997;
Zelante et al. 1997). These studies indicate that DFNB1
causes 20% of all childhood deafness and may have a
carrier rate as high as 2.8%.
Connexins are a class of membrane proteins that form
hexameric connexons that form gap-junction channels
with identical or similar connexons in adjacent cells
(Paul 1995; Bruzzone et al. 1996). Gap junctions con-
stitute a major system of intercellular communication
important in the exchange of electrolytes, second mes-
sengers, and metabolites (Dermietzel and Spray 1993;
White et al. 1995; White and Bruzzone 1996). Connex-
ins may play important roles in development, by coor-
dinating the clonal development of groups of cells. Katz
(1995) has proposed that connexin expression may di-
rect the assembly of complex functional architecture in
the developing brain by laying the foundation of cortical
circuits that mature by synapse formation. In mammals,
there are ∼13 different connexin genes, which are di-
vided into two classes, alpha and beta, on the basis of
their primary structure (Kumar and Guila 1992, 1996).
Some forms of connexin are expressed in a wide variety
of tissue, whereas others are restricted to specific cell
types. Turnover of connexins appears to be rapid, sug-
gesting that the levels of most forms are dependent on
transcription or mRNA turnover. Cx26 is downregu-
lated in tumor tissue and thus is considered a class II
tumor-suppressor gene. Cx26 is strongly upregulated in
synchronized cells, during the S and G2 phases (Lee et
al. 1992).
Immunostaining of rat cochlea, with antisera raised
against cytoplasmic epitopes of Cx26, revealed that two
groups of cochlear cells use the Cx26 protein (Kikuchi
et al. 1995). The first group of cells includes interdental
cells of the spiral limbus, inner sulcus cells, organ of
Corti supporting cells, outer sulcus cells, and cells within
the root process of the spiral ligament; these are all non-
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sensory epithilial cells. The second group includes fibro-
cytes of the spiral limbus and spiral ligament, basal and
intermediate cells of the stria vascularis, and mesenchy-
mal cells lining the scala vestibuli; these are all connec-
tive-tissue cells. This observation supports the hypoth-
esis that Cx26 mediates the recycling of endolymphatic
potassium ions transiting the hair cells during the trans-
duction process (Schulte and Steel 1994; Spicer and
Schulte 1996).
We have begun an analysis of 58 multiplex families,
each with at least two affected children diagnosed with
autosomal recessive nonsyndromic deafness. The pur-
pose of this study was to estimate the frequency of Cx26
mutation in the population of American families with
nonsyndromic hearing loss and to identify novel
mutations.
Subjects and Methods
Criteria for Inclusion in This Study
Families were included in this study if the following
criteria were met (1) both parents are living and have
normal hearing; (2) there exist at least two hearing-im-
paired siblings; (3) hearing loss is documented by au-
diologic testing in a clinical facility; and (4) there is no
evidence of any obvious syndrome. All of the recessive
nonsyndromic hearing-loss (RNSHL) families assembled
were tested. A single dominant nonsyndromic hearing-
loss family was tested, because of preliminary data link-
ing it to the DFNA3 locus. Ethnicity and country of
origin were self-assessed. The families included in this
study are all American, primarily from Midwestern
states. They are primarily Caucasian and are of northern
and southern European origin. No Asian, African, or
Native American families were available to us for this
study.
Mutation Detection
Two methods of mutation detection were used in this
study: heteroduplex analysis and sequencing. Hetero-
duplex analysis was done on an affected individual and
the individual’s parents, for each family. We focused our
search for mutations on the coding region of Cx26. After
the initial screen by heteroduplex analysis, we sequenced
the entire coding region from at least one affected mem-
ber of each family.
DNA samples were prepared for analysis by PCR am-
plification with the following primer pairs: Cx26A-U/
Cx26A-L (TCT TTT CCA GAG CAA ACC GC/GAC
ACG AAG ATC AGC TGC AG) (Kelsel et al. 1997),
Cx342-U/Cx739-L (AGG CCG ACT TTG TCT GCA
ACA/GTG GGC CGG GAC ACA AAG), Cx637-U/
Cx1129-L (CGA AGC CGC CTT CAT GTA CG/GTG
GGC CGG GAC ACA AAG). PCR products with these
three amplimer pairs cover the entire coding region of
Cx26 and were used for heteroduplex analysis. The pri-
mer pair CxG4352-U/Cx873-L (TCG GCC CCA GTG
GTA CAG/CTG GGC AAT GCG TTA AAC TGG) am-
plifies the entire coding region and was used to produce
a template for sequencing. Amplification conditions
were as follows: reaction volume was 50 ml with a final
concentration of Tris-HCl, pH 8.3, at 10 mM, KCl at
50 mM, MgCl2 at 1.5 mM, dNTPs at 200 uM, AmpliTaq
Gold (PE Applied Biosystems) at 1.25 units/50 ml, prim-
ers at 400 nM, and template genomic DNA at 200 ng/
50 ml. Part (5 ml) of the PCR reaction volume was an-
alyzed on a 2% agarose gel to verify the size and quantity
of the PCR product.
Heteroduplex analysis was done by use of a mutation-
detection enhancement (MDE) gel and a protocol pro-
vided by the manufacturer (FMC Bioproducts). Part
(5–10 ml) of the PCR-reaction volume was incubated at
95C for 3 min then was slow cooled for 30 min, to
37C. This renatured DNA was mixed with loading buf-
fer and was separated on a 1# MDE gel, according to
the manufacturer’s directions, for 14–20 h at 800 V.
Homoduplexes and heteroduplexes were visualized on
a UV transilluminator, after staining in ethidium bro-
mide (1 mg/ml) for 15 min.
Genomic DNA was PCR amplified as described above.
After verification on 2% agarose gels, the PCR products
were prepared for sequencing. The PCR-reaction mix
was diluted with 450 ml of distilled water and was sep-
arated from unincorporated nucleotides and primers, on
a Microcon-100 (Millipore). Sequencing was accom-
plished by use of the ABI Prism dRhodamine Terminator
Cycle Sequencing Ready Reaction Kit (PE Applied Bios-
ystems) or the ABI Prism BigDye Terminator Cycle Se-
quencing Ready Reaction Kit and an ABI 377 DNA
sequencer. In general, PCR products were sequenced in
both directions.
Cloning Heterozygotes
When deletions in one allele obscured a clear reading
of the sequence, the PCR products were clone purified
by use of the Original TA Cloning Kit (Invitrogen). PCR
products were ligated, to pCR2.1, overnight at 15C
then were transformed into competent INValphaF′ Es-
cherichia coli. Transformed cells were plated on Luria-
Bertani (LB)/ampicillin/X-Gal plates. White colonies
were picked into 25 ml of LB. Part (2.5 ml) of this bac-
terial suspension was used as a template in PCR reac-
tions, under the conditions described above. PCR prod-
ucts from 10 colonies usually sufficed to provide
sequence from both alleles.
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Table 1










Group Mutation Type Reference(s)a
10 30delG 33 2 Deletion/frameshift 1, 2, 3
10 31–68del(38) ) ) Deletion/frameshift 2
W24X 74GrA ) ) Nonsense 4
V27I 79GrA ) 1 Polymorphism
M34T 101TrC 2 3 Missense 4, 5
V37I 109GrA ) 1 Polymorphism
E47X 139GrT ) ) Nonsense 2
55 167delT 9 ) Deletion/frameshift 3
W77R 229TrC ) ) Missense 1
W77X 231GrA ) ) Nonsense 4
V84L 250GrC 1 ) Missense
V95M 283GrA 1 ) Missense
105 314–327del(14) 2 ) Deletion/frameshift
111 333–334del(AA) 1 ) Deletion/frameshift
S113R 339TrG 1 ) Missense
211 631–632del(GT) 1 ) Deletion/frameshift
a 1  Carrasquillo et al. 1997; 2  Denoyelle et al. 1997; 3  Zelante et al. 1997; 4  Kelsell et al.
1997; and 5  Scott et al. 1998.
Results
Three mutations found in this study have been de-
scribed elsewhere. The 30delG mutation (Carrasquillo
et al. 1997; Denoyelle et al. 1997; Zelante et al. 1997)
was the most common mutation found in the current
study (table 1). Fourteen families were homozygous for
this mutation, four families were compound heterozy-
gous, and one family was heterozygous but with no other
mutation detectable. This deletion results in a frameshift
converting codon 12 from GGT glycine to GTG valine,
followed by a stop codon at position 13. A 167delT,
also previously described by Zelante et al. (1997), was
the second-most-common mutation found. This muta-
tion was homozygous in three families and heterozygous
in three families, one of which was a compound heter-
ozygote. It is interesting to note that all of these families
reported Jewish origin. This deletion causes a frameshift
at codon 56, resulting in a polypeptide that has the first
55 amino acids intact but that ends prematurely with a
novel 25–amino-acid polypeptide C terminus. The third
mutation, found in two families, was 101TrC and has
been described elsewhere as a dominant allele of DFNA3
(Kelsell et al. 1997). In one family, we found this mu-
tation segregating as a putative recessive allele from the
father, who had normal hearing (fig. 1, family 1617).
Both parents of the affected individual had normal hear-
ing. Linkage data do not exclude a mutation on chro-
mosome 13 as causative for hearing loss in family 1617.
In this family, a second mutation, missense mutation
283GrA, Val95Met (fig. 2), was derived from the
mother (fig. 1, family 1617). Codon 95 codes for an
invariant valine in all beta-group connexins, although
both a methionine and an alanine are found, in addition
to a valine, in alpha-group connexins. A second family
(fig. 1, family 1619) had the 101TrC mutation, but the
mutation did not segregate with the hearing-loss phe-
notype. This allele was evident in the paternal grand-
mother and the father but was not accompanied by the
hearing-loss phenotype.
Missense Mutations
In addition to the missense mutation (Val95Met) de-
scribed above, two other novel missense mutations were
detected. The second missense mutation was Val84Met,
250GrC (fig. 2). The valine at this position is invariant
in all known alpha and beta connexin genes. This mu-
tation was inherited from the maternal grandfather,
through the mother (fig. 3, family 1612). The third mis-
sense mutation was Ser113Arg, 339TrG (fig. 2). Al-
though this mutation does not change a conserved res-
idue, it causes a radical change from a small polar group
to a bulky charged group.
Small Deletions
In addition to the two common deletions reported
above, three new small deletions have been detected. A
14-bp deletion, 314–327del(14), was found in two fam-
ilies (fig. 4). This deletion causes a frameshift following
codon 105, resulting in four additional novel amino ac-
ids and premature termination at codon 110. This mu-
tation was inherited from the mother, in one of the fam-
ilies (fig. 3, family 1599). A second new small-deletion
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Figure 1 Pedigree and sequence summary for families with
101TrC. Below the pedigrees are shown the sequences of the indi-
vidual patients, at position 101 or 283 (position 1 is the first base in
the first codon of GJB2), derived from PCR amplimer CxG4352-U/
Cx873-L by use of Cx26A-U as the sequencing primer, for family 1617,
and the base at position 101, for family 1619. The family number is
given above each pedigree.
mutation, 333-334del(AA), was observed at codon 111
(fig. 4) in a single family. This deletion causes a frame-
shift resulting in chain termination after an additional
novel amino acid. This deletion was inherited from the
paternal grandfather, through the father (fig. 3, family
1621). A third, 2-bp deletion, 631-632del(GT), was ob-
served at codon 211 in a single family (fig. 4) and results
in a frameshift and terminates the polypeptide product
four codons downstream. This mutation was inherited
from the mother (fig. 3, family 1692).
Mutations Found in Unaffected Controls
DNA from 96 unrelated individuals known not to
have noticeable hearing loss were analyzed for their
Cx26 genotype. PCR products were analyzed by het-
eroduplex analysis, to detect mutations or polymor-
phisms. For primers Cx26A-U/Cx26A-L, eight hetero-
zygous changes were detected, and DNA from
individuals with these changes was sequenced. Three in-
dividuals had the previously described dominant mis-
sense mutation 101TrC. Two individuals had the de-
letion frameshift mutation 30delG, described above.
Two novel changes were detected, both resulting in con-
version of a valine codon to an isoleucine, at codon 27
(79GrA) and at codon 37 (109GrA) (also see table 1).
No mutations in the Cx26 coding region were found in
the one dominant family that linked to chromosome 13.
Discussion
The structure and function of human connexins have
been extensively studied at the biochemical and physi-
ological levels. Studies of mutant forms of connexin have
preceded their connection to human disease. Site-di-
rected mutagenesis and domain replacement forms of
human Cx26 have aided in the definition of important
and essential elements of connexin primary structure
(Rubin et al. 1992; Ek et al. 1994). The topology of
Cx26 has been verified by use of specific antibodies and
partial proteolysis (Zhang and Nicholson 1994) (fig. 5).
Cx26, like other connexins, has a common sequence of
structural motifs. The N-terminal domain (fig. 5), to-
gether with the transmembrane domain M1 border,
forms a charge complex that acts as a voltage sensor
(Verselis et al. 1994). The extracellular domains E1 and
E2 determine the heterotypic compatibility, whereas the
cytoplasmic linking (CL) domain and the C-terminal do-
main are involved in pH gating of the channel. Con-
nexins are unique among integral multimeric membrane
proteins in that they do not oligomerize within the en-
doplasmic reticulum (Laird 1996). This assembly ap-
pears to occur in the trans-Golgi network (TGN) and
may be dependent on an undefined TGN chaperone.
The most common Cx26 mutation found in the 58
RNSHL families analyzed was a G deletion converting
a GGGGGG to a GGGGG, 30delG. This results in a
change from a glycine residue at codon 12 to a valine
residue and a stop codon at position 13. A possible or-
igin of this mutation is due to slipped mispairing during
DNA synthesis (Cooper and Krawczak 1993). The site
of the mutation, TGGGGGG, is very similar to a con-
sensus deletion–hot spot sequence, TG(A/G)(A/G)(G/
T)(A/C). The frequency of this mutation in a control
(unaffected) population was 2/192 chromosomes, or ap-
proximately 1%, which is consistent with the high fre-
quency we found in the affected population. This allele
has also been reported as the most common form found
in Mediterranean families (Zelante et al. 1997). It was
also found in a heterozygous state in a Muslim Israeli-
Arab kindred (Carraquillo et al. 1997). Denoyelle et al.
(1997) found this mutation in the homozygous state in
19 families and in the heterozygous state in 16 families.
These families originated from Tunisia, France, New
Zealand, and the United Kingdom. One of their families
had a second deletion, 31del38, beginning in the same
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Figure 2 Sequences of novel missense mutations. Electropherograms from an ABI 377XL DNA sequencer are shown. An arrow indicates
the location of the base change.
Figure 3 Pedigrees of RNSHL families and individual sequence summaries. Below the pedigrees are shown the sequences of the individual
patients, at the positions indicated, derived from PCR amplimer CxG4352-U/Cx873-L by use of Cx26A-U or Cx432-U as the sequencing primer.
A hyphen (-) indicates the deletion allele; and a plus sign () indicates the normal sequence. The family number is given above each pedigree.
No DNA was available from the second affected son in family 1692, and, therefore, the sequence is marked “nd,” for “not done.”
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Figure 4 Sequences of novel small-deletion mutations. Electropherograms from an ABI 377XL DNA sequencer are shown. An arrow
indicates the location of the deletion.
GGGGGG sequence. These findings further support the
hypothesis that this site is a mutational hot spot. The
30delG mutation would appear to be the most common
cause of RNSHL in northern and southern European
populations. The estimated gene frequency is .01
, based on our control population of 96 unaffected.007
families. The homozygous frequency of the 30delG mu-
tation then was estimated at .0001, or 1/10,000. Given
that the frequency of all childhood hearing impairment
is 1/1,000 and that half of that is genetic, the specific
mutation 30delG is responsible for 10% of all childhood
hearing loss and for 20% of all childhood hereditary
hearing loss. This places Cx26 in the same category of
common recessive disorders as cystic fibrosis, sickle-cell
anemia, and Tay-Sachs disease. If the hypothesis re-
garding the hypermutable nature of the GGGGGG motif
is correct, the same high frequency of 30delG should
occur in all ethnic groups worldwide.
The missense mutation 101TrC has been reported to
be a dominant allele of DFNA3 (Kelsell et al. 1997).
Our data indicate that this mutation may not have a
dominant effect. In one of our RNSHL families the
101TrC allele segregated independently from the hear-
ing-loss phenotype. Furthermore, we have found this
mutation in 3 of 192 control chromosomes, for a fre-
quency of ∼1.5%. Our data indicate that the 101TrC
mutation is not sufficient to cause hearing loss. Scott et
al. (1998) also detected this mutation in the heterozy-
gous state in their control population. The frequency of
the 101TrC mutation in both control populations sug-
gests that the incidence of homozygous affected individ-
uals to be similar to the incidence of affected individuals
having the 30delG mutation (∼1/10,000). This suggests
that the 101TrC mutation has no effect on hearing loss.
However, no individual homozygous for 101TrC has
been detected yet. Such an individual would clarify the
role of 101TrC in causing nonsyndromic hearing-loss
type DFNB1. Our observations, however, do not rule
out the possibility of an interaction of 101TrC with a
second gene, at the same or another locus, to exert a
dominant effect. In vitro and in vivo studies indicate that
specific heterotypic channels can form that have com-
munication properties distinct from homotypic channels.
Connexin 32 (Cx32) mutations are causative for X-
linked dominant Charcot-Marie-Tooth neuropathy
(CMTX). CMTX also causes deafness in some families.
In vitro studies indicate a dominant negative effect on
Cx26 activity by some Cx32 mutants (Bruzzone et al.
1994). A mutation in a second connexin gene, such as
the CMTX gene, might act with a specific allele of GJB2
to cause a digenic form of deafness that could exhibit a
dominant pattern of inheritance.
Three of the new frameshift mutations discovered
eliminate major functional domains of Cx26 and are
presumed to severely disrupt the topological state of
these polypeptides. A deletion frameshift at codon 104
in the CL domain (fig. 5) terminates four later codons,
eliminating two transmembrane domains, the E2 do-
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Figure 5 Schematic representation of Cx26 and its mutations.
NT  N-terminal domain; M1, M2, M3, and M4  transmembrane
domains; E1 and E2  extracellular domains; CL  cytoplasmic link-
ing domain; and CT  C-terminal domain. Underlined numbers next
to a frameshift or deletion arrow indicate the number of residues, after
the frameshift, before a termination codon is found. The polypeptide
chain is numbered every 20th residue. Mutation type is designated
according to the key at the bottom of the figure.
main and the C-terminal domain. This 14-bp deletion
is flanked by a 2-bp GA repeat that may have allowed
slipped mispairing during DNA synthesis. A second de-
letion at codon 111 terminates two later codons, with
similar consequences. A 2-bp deletion mutation at codon
210 causes a frameshift and termination four codons
downstream, eliminating the C-terminus domain.
Three novel missense mutations were found. One of
the mutations, Val84Met, occurs in the second trans-
membrane domain, M2 (fig. 5). This methionine replaces
an invariant valine. The next missense mutation,
Val95Met, is a similar change occurring at the interface
of the CL domain and the M2 domain. The pathologic
significance of this change is more difficult to explain,
since a methionine has been found in this position in
alpha connexins; however, only valine has been found
in beta connexins such as Cx26. An additional missense
mutation is found at codon 113, where a serine codon
has been replaced with an arginine codon in the middle
of the CL domain. Two other changes have been found
only in unaffected controls and may represent poly-
morphic changes. Both occur in the M1 domain and
involve the conversion of a valine codon to an isoleucine
codon (Val27Iso and Val37Iso). Val27Iso is at an in-
variant valine, in all connexins. Val37Iso is at an invar-
iant valine, in beta connexins. In alpha connexins, gly-
cine, serine, and alanine, but not valine, codons are
found at that position. Since these mutations were ob-
served only as heterozygotes, the possible pathologic sig-
nificance must await further studies.
The frequency of childhood deafness is ∼.001, or
1/1,000 (Van Camp et al. 1997). Half of this hearing
loss is genetic, whereas about half of this genetic hearing
loss is recessive nonsyndromic. This study indicates that
∼40% (49/116 chromosomes, excluding 101TrC) of
childhood nonsyndromic hearing loss is caused by mu-
tations in DFNB1. These data suggest that ∼20% of all
childhood hearing loss is caused by mutations in
DFNB1, most by the 30delG mutation, for a frequency
of .0001, or 1/10,000, of all childhood hearing loss. No
consistent audiologic phenotype was observed in indi-
viduals with mutations in Cx26. Hearing loss varied
from mild to profound even within the group of families
homozygous for the common mutation 30delG. These
results suggest that other factors may significantly mod-
ify the effects of mutations in Cx26.
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